Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages (Q39715544)

14 September 2017

Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages (English)

1 reference

14 September 2017

0 references

Qingshan Wang

1

1 reference

14 September 2017

Hong Ni

2

1 reference

14 September 2017

Lan Lan

3

1 reference

14 September 2017

Xiaoli Wei

4

1 reference

14 September 2017

Rong Xiang

5

1 reference

14 September 2017

Yue Wang

6

1 reference

14 September 2017

13 April 2010

1 reference

14 September 2017

1 reference

14 September 2017

20

1 reference

14 September 2017

701-712

1 reference

14 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2010.52

14 September 2017

0 references

cites work

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Targeting tumor-associated macrophages as a novel strategy against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Significance of interleukin-6 (IL-6) in breast cancer (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

The Fos family of transcription factors and their role in tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

AP-1 as a regulator of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

Malignancy: Identification of Predictors of Disease Status and Progression in Patients with Myeloma (MM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

7 January 2021

Multiple myeloma: An immunoclinical study of disease and response to treatment

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

7 January 2021

IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

7 January 2021

IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

7 January 2021

IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.52

7 January 2021

Identifiers

DOI

10.1038/CR.2010.52

1 reference

14 September 2017

1 reference